These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16439884)

  • 1. Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev.
    Makadzange AT; Gillespie G; Kimani J; Kiama P; Easterbrook P; Bwayo JJ; Rowland-Jones SL
    AIDS; 2006 Feb; 20(3):462-4. PubMed ID: 16439884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
    Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
    AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocyte recognition of HLA-B*5101-restricted HIV-1 Rev epitope which is naturally processed in HIV-1-infected cells.
    Tomiyama H; Chujoh Y; Shioda T; Miwa K; Oka S; Kaneko Y; Takiguchi M
    AIDS; 1999 May; 13(7):861-3. PubMed ID: 10357388
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection.
    Goulder PJ; Bunce M; Krausa P; McIntyre K; Crowley S; Morgan B; Edwards A; Giangrande P; Phillips RE; McMichael AJ
    AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1691-8. PubMed ID: 8959245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.
    Goulder PJ; Edwards A; Phillips RE; McMichael AJ
    AIDS; 1997 Jun; 11(7):930-2. PubMed ID: 9189221
    [No Abstract]   [Full Text] [Related]  

  • 6. Effective recognition of HIV-1-infected cells by HIV-1 integrase-specific HLA-B∗4002-restricted T cells.
    Watanabe T; Murakoshi H; Gatanaga H; Koyanagi M; Oka S; Takiguchi M
    Microbes Infect; 2011 Feb; 13(2):160-6. PubMed ID: 20971209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential characteristics of cytotoxic T lymphocytes restricted by the protective HLA alleles B*27 and B*57 in HIV-1 infection.
    Schellens IM; Spits HB; Navis M; Westerlaken GH; Nanlohy NM; Coffeng LE; Kootstra N; Miedema F; Schuitemaker H; Borghans JA; van Baarle D
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):236-45. PubMed ID: 25171732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals.
    Hashimoto M; Kitano M; Honda K; Koizumi H; Dohki S; Oka S; Takiguchi M
    Hum Immunol; 2010 Feb; 71(2):123-7. PubMed ID: 19891998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
    Altfeld M; Addo MM; Rosenberg ES; Hecht FM; Lee PK; Vogel M; Yu XG; Draenert R; Johnston MN; Strick D; Allen TM; Feeney ME; Kahn JO; Sekaly RP; Levy JA; Rockstroh JK; Goulder PJ; Walker BD
    AIDS; 2003 Dec; 17(18):2581-91. PubMed ID: 14685052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unanticipated lack of consensus cytotoxic T lymphocyte epitopes in HIV-1 databases: the contribution of prediction programs.
    Schellens IM; Keşmir C; Miedema F; van Baarle D; Borghans JA
    AIDS; 2008 Jan; 22(1):33-7. PubMed ID: 18090389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.
    Gillespie GM; Kaul R; Dong T; Yang HB; Rostron T; Bwayo JJ; Kiama P; Peto T; Plummer FA; McMichael AJ; Rowland-Jones SL
    AIDS; 2002 May; 16(7):961-72. PubMed ID: 11953462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients.
    Harrer EG; Bergmann S; Eismann K; Rittmaier M; Goldwich A; Müller SM; Spriewald BM; Harrer T
    AIDS; 2005 Apr; 19(7):734-5. PubMed ID: 15821402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel HLA-B*2705-restricted cytotoxic T-lymphocyte epitope within a conserved region of HIV-1 Nef.
    Goulder PJ; Edwards A; Phillips RE; McMichael AJ
    AIDS; 1997 Mar; 11(4):536-8. PubMed ID: 9084804
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
    Willberg CB; Garrison KE; Jones RB; Meiklejohn DA; Spotts G; Liegler TJ; Ostrowski MA; Karlsson AC; Hecht FM; Nixon DF
    PLoS One; 2010 Apr; 5(4):e10249. PubMed ID: 20422053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load.
    Frahm N; Adams S; Kiepiela P; Linde CH; Hewitt HS; Lichterfeld M; Sango K; Brown NV; Pae E; Wurcel AG; Altfeld M; Feeney ME; Allen TM; Roach T; St John MA; Daar ES; Rosenberg E; Korber B; Marincola F; Walker BD; Goulder PJ; Brander C
    J Virol; 2005 Aug; 79(16):10218-25. PubMed ID: 16051815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
    Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
    Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles.
    Day CL; Shea AK; Altfeld MA; Olson DP; Buchbinder SP; Hecht FM; Rosenberg ES; Walker BD; Kalams SA
    J Virol; 2001 Jul; 75(14):6279-91. PubMed ID: 11413294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.
    Bihl F; Frahm N; Di Giammarino L; Sidney J; John M; Yusim K; Woodberry T; Sango K; Hewitt HS; Henry L; Linde CH; Chisholm JV; Zaman TM; Pae E; Mallal S; Walker BD; Sette A; Korber BT; Heckerman D; Brander C
    J Immunol; 2006 Apr; 176(7):4094-101. PubMed ID: 16547245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-A*3303-restricted cytotoxic T lymphocyte recognition for novel epitopes derived from the highly variable region of the HIV-1 Env protein.
    Hossain MS; Tomiyama H; Inagawa T; Sriwanthana B; Oka S; Takiguchi M
    AIDS; 2001 Nov; 15(16):2199-201. PubMed ID: 11684944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.